Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessing Safety and Efficacy of Repurposed Oral Ivermectin in PKDL Treatment

NCT06251739 is registered in ClinicalTrials.gov with International Centre for Diarrhoeal Disease Research, Bangladesh as lead sponsor.

NCT NCT06251739
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06251739 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessing Safety and Efficacy of Repurposed Oral Ivermectin in PKDL Treatment
Lead sponsor
International Centre for Diarrhoeal Disease Research, Bangladesh
Phase
Phase 1
Overall status
Completed
Start date
October 30, 2023
Completion date
January 1, 2025
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

post-kala-azar dermal leishmaniasis